Endocrinology practice marketing: claims and ads

An endocrinology practice treats conditions that patients live with for years: thyroid disease, diabetes, bone loss and hormone disorders. A patient may arrive on a referral from their primary care clinician and look you up to check the details, or search on their own because they are tired, gaining or losing weight, or worried about a lump in the neck. Either way, they need pages that explain the condition clearly, set honest expectations and make the next step easy.

This guide covers endocrinology and thyroid practice marketing: condition pages, symptom content, treatment and nodule pages, bone density, free screenings, patient stories, referrals and ads. Several neighboring topics already have their own guides, and we link to them instead of repeating them. For GLP-1 drugs, compounded versions and weight loss claims, see our guide to weight loss clinic marketing. For diabetes education programs and Medicare DSMT wording, see diabetes education program marketing. For menopause and hormone therapy pages, see menopause clinic marketing. Practices that refer patients for weight loss surgery should read bariatric surgery marketing.

This is general information, not legal or medical advice. Sources cited were checked on October 29, 2026: NIDDK pages on hypothyroidism (last reviewed March 2021) and hyperthyroidism (last reviewed August 2021), MedlinePlus on thyroid nodules (review date May 18, 2026), Medicare.gov on bone mass measurements, 42 U.S.C. 1320a-7a, the OIG policy statement on gifts of nominal value (December 7, 2016), 21 CFR 101.93, the FTC Health Products Compliance Guidance, 15 U.S.C. 45, 16 CFR 255.2, 45 CFR 164.508 and Google Ads policies. Have your clinical leadership and counsel review your own pages.

Condition pages that match how patients search

Patients search for “underactive thyroid”, “overactive thyroid” and “thyroid nodule”, not for a practice’s list of services. A page for each condition you treat, titled in the patient’s words with the clinical term explained once, gives search engines and patients something specific to find. NIDDK, part of the National Institutes of Health, uses exactly that pairing: it describes hypothyroidism, also called underactive thyroid, as when the thyroid gland does not make enough thyroid hormones to meet the body’s needs, and hyperthyroidism, also called overactive thyroid, as when the thyroid makes more thyroid hormones than the body needs.

One page per condition: what it is in plain words, the symptoms that bring patients in, how your providers evaluate it, the categories of treatment your practice offers and how to book.
One page per test or procedure you perform, such as thyroid ultrasound, fine needle aspiration biopsy or bone density testing, with what to expect before, during and after.
A provider page for each endocrinologist and advanced practice clinician, with accurate credentials. Our guide to physician bio pages and board certification covers the wording.
A referral page for clinicians that says what to send, how to reach you and how you report back. Our guide to patient and physician referrals covers the rules around referral relationships.

Statistics on these pages need the same care as any other claim. NIDDK states that nearly 5 out of 100 Americans ages 12 years and older have hypothyroidism, although most cases are mild or have few obvious symptoms, and that about 1 out of 100 Americans ages 12 years and older have hyperthyroidism. If you quote figures like these, quote them exactly, including qualifiers such as “most cases are mild”, name the source and link to it. A population estimate is not a statement about the person reading the page.

Symptom pages and online quizzes

“Do I have a thyroid problem?” is a natural search, and symptom content can bring the right patients to you. It can also overstate what symptoms mean. NIDDK lists symptoms of hypothyroidism that include fatigue, weight gain, trouble tolerating cold and dry skin, and then says that many of these symptoms, especially fatigue and weight gain, are common and do not necessarily mean you have a thyroid problem. It also says a hypothyroidism diagnosis cannot be based on symptoms alone, because many of its symptoms are the same as those of other diseases.

That gives you a clear line for symptom pages and quizzes. Listing symptoms and suggesting a visit to find out what is behind them matches the federal wording. A quiz that ends with “You may have hypothyroidism, book now”, or an ad that says “Tired all the time? It is your thyroid”, tells readers something NIDDK says symptoms cannot show. Write the result as an invitation to an evaluation, not as a finding.

List symptoms as reasons to get checked, and say that symptoms alone do not confirm a diagnosis.
Do not present a quiz score as a diagnosis or a risk level unless a validated tool and your clinicians stand behind it.
Keep quiz answers off ad platforms. A symptom quiz on a health topic collects health information, and the tracking section below applies to it.
If you offer lab testing directly to consumers, our guide to direct-to-consumer lab testing marketing covers who may order tests and how to describe results.

Treatment pages: describe choices, not guarantees

Thyroid treatment pages work best when they explain the options the way federal patient education does. NIDDK says hyperthyroidism is treated with medicines, radioiodine therapy or thyroid surgery, that no single treatment works for everyone, and that the choice depends on what is causing the condition and how severe it is. It also states plainly that almost everyone who gets radioiodine therapy later develops hypothyroidism. A radioiodine page that leaves that out, or that says the treatment “cures” an overactive thyroid without explaining what comes after, gives patients a less accurate picture than the government’s own page does.

For hypothyroidism, NIDDK says treatment replaces the hormones the thyroid can no longer make. Pages about thyroid medicine should describe the evaluation and follow-up your clinicians provide, not promise that patients will feel a certain way or reach a certain weight. Do not name prescription drug brands in ads or on landing pages without checking the Google policy covered below.

Thyroid nodule pages need special care, because the reader may be frightened. MedlinePlus, from the National Library of Medicine, says thyroid nodules are very common, that only a few are due to thyroid cancer, and that many do not require treatment. It lists the tests that may be done, including TSH and other thyroid blood tests, thyroid ultrasound, a thyroid scan and fine needle aspiration biopsy. A nodule page built on those facts can explain your evaluation calmly. A page or ad that leans on cancer fear to drive bookings works against what the patient education says.

Weight, hormones and supplements

Endocrinology overlaps with three areas that carry their own rules, and each has its own guide. Weight management and GLP-1 medicines, including the FDA position on compounded versions, are covered in our weight loss clinic marketing guide. Menopause and hormone therapy pages are covered in menopause clinic marketing. If your practice sells supplements, our guide to functional medicine practice marketing covers the FDA disclaimer for structure and function claims.

One point is worth repeating for thyroid and adrenal products in particular. Under 21 CFR 101.93(g), if the label or labeling of a product marketed as a dietary supplement makes a disease claim, such as a claim to treat or prevent a thyroid disease, the product will be subject to regulation as a drug unless the claim is an authorized health claim for which the product qualifies. A practice page that sells a “thyroid support” supplement next to its hypothyroidism page should be reviewed with that in mind.

Bone density pages and Medicare wording

If your practice offers bone density testing, it is a service where Medicare coverage is a factual point you can state if it applies to your patients. Medicare.gov says Part B covers bone mass measurements once every 24 months, or more often if medically necessary, for people who meet one or more listed conditions, and that the patient pays nothing for the test if the provider accepts assignment. The listed conditions include an estrogen-deficient woman at risk for osteoporosis as determined by her doctor, X-rays showing possible osteoporosis, osteopenia or vertebral fractures, taking or planning to begin prednisone or steroid-type drugs, a diagnosis of primary hyperparathyroidism, and monitoring of osteoporosis drug therapy.

Quote the conditions as Medicare.gov lists them, and avoid “free bone density scan for everyone on Medicare”. Coverage depends on eligibility and on assignment. Our guide to marketing to Medicare patients covers the wider rules for that audience.

Practices that share diabetes and kidney patients with a nephrologist can point to our nephrology practice marketing guide, which covers kidney disease education, claims about kidney care and how to present dialysis and transplant choices.

Free screenings, gifts and Medicare patients

Free thyroid checks at community events, free glucose meters or gift cards for new patients can look like simple goodwill. When Medicare or Medicaid patients are involved, they raise a federal question. Under 42 U.S.C. 1320a-7a(a)(5), offering or transferring remuneration to a Medicare or Medicaid beneficiary that the person knows or should know is likely to influence the beneficiary’s selection of a particular provider, practitioner or supplier can lead to civil monetary penalties. The statute defines remuneration to include transfers of items or services for free or for other than fair market value, with limited exceptions.

The OIG policy statement dated December 7, 2016 interprets nominal value as a retail value of no more than $15 per item or $75 in the aggregate per patient on an annual basis, and says the items may not be cash or cash equivalents. A branded water bottle at a health fair is a different question from a free device or a gift card. Our guide to health fairs and free screening events covers screening events in more detail, and your counsel should review any offer aimed at Medicare or Medicaid patients.

Claims, testimonials and patient stories

Endocrinology practices are not selling a product, but the same caution makes sense: the FTC approach generally requires that health-related claims be backed by competent and reliable scientific evidence. The FTC Act prohibits unfair or deceptive acts or practices in or affecting commerce under 15 U.S.C. 45, and the FTC Health Products Compliance Guidance looks at the net impression of an ad, including claims implied by images and context. On an endocrinology site, implied claims can come from phrases like “get your energy back”, “fix your metabolism” or “balance your hormones”.

Patient stories need two separate checks. Under 16 CFR 255.2(b), an endorsement about a key attribute of a service will likely be read as representing what people will generally achieve, so if a story is not representative, you need to clearly disclose what patients can generally expect. And because a testimonial tells the world that a person was your patient, using it in marketing generally requires a signed HIPAA authorization under 45 CFR 164.508(a)(3). Our guides to patient testimonials and patient photo and video consent cover the process.

Ads and tracking for endocrinology services

Google’s Healthcare and medicines policy allows prescription drug ads only in select locations and from certain advertisers, restricts prescription drug terms in ads, landing pages and keywords, and says advertisers must apply to serve ads for prescription drug services. Check it before any endocrinology ad or landing page names a prescription medicine. Google’s personalized advertising policy also lists Health among its sensitive interest categories and says advertisers promoting products and services in those categories cannot use advertiser-curated audiences, such as remarketing lists.

Search campaigns built around condition keywords and matching condition pages fit those limits. Keep advertising pixels off booking forms, symptom quizzes and condition pages, so a visit to your thyroid nodule page is not sent to ad platforms. Our guide to tracking pixels on practice websites explains why, and the Google Ads for practices page describes how we set up campaigns.

Illustration: reworking a thyroid landing page

Illustration. An endocrinology practice runs an ad that says “Exhausted and gaining weight? Your thyroid could be the reason”. It leads to a page with a five-question quiz that ends with “You likely have hypothyroidism”, a patient quote saying they lost 20 pounds after her first visit, and an offer of a free thyroid panel for new patients. A pixel on the page reports quiz completions to an ad platform for remarketing.

Ad and quiz. The ad now invites people with symptoms to get checked, without saying what the cause is. The quiz result says that symptoms alone cannot confirm a diagnosis, citing NIDDK, and offers an evaluation.
Patient quote. The practice confirms it has a signed authorization. The weight figure describes a result that is not representative, so the practice removes the quote.
Free panel. Counsel reviews the offer under 42 U.S.C. 1320a-7a(a)(5), since a free lab panel is a service and not a gift of nominal value. The practice withdraws it for Medicare and Medicaid patients or drops it entirely, as counsel advises.
Tracking. The pixel comes off the quiz and the page, the remarketing list is removed and the campaign runs on search keywords that match the condition page.

Checklist

One page per condition, test and procedure, in patient words, with clinical terms explained once.
NIDDK and other statistics quoted exactly, with their qualifiers, the source named and linked.
Symptom pages and quizzes that invite an evaluation and never present a result as a diagnosis.
Treatment pages that describe the options and trade-offs, including what comes after radioiodine therapy.
Nodule pages built on calm facts, not cancer fear.
GLP-1, menopause and supplement content checked against the guides linked above.
Medicare bone density wording quoted with its eligibility conditions.
Free screenings, devices and gifts for Medicare or Medicaid patients reviewed by counsel against 42 U.S.C. 1320a-7a(a)(5).
Signed authorizations for every patient story, and a clear statement of typical experience when a story is not representative.
No remarketing lists for health topics, and no ad pixels on condition pages, quizzes or booking forms.

A clinic built around thyroid care, including one that markets lab ranges, Hashimoto’s programs, supplements or animal-derived thyroid medicine, has claims of its own to check. Our guide to thyroid clinic marketing covers them.

How we help

We build websites, local search, Google Ads and AI front desk tools for independent practices. For an endocrinology practice, that means condition, test and procedure pages written in plain language from your own clinical protocols, symptom content that leads to an evaluation instead of a verdict, a referral page for clinicians, and campaigns set up without remarketing on health topics. Clinical content is reviewed and approved by your providers before it goes live. Our work is built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it.

Can our website say how many people have thyroid disease?

Yes, if you quote the figure exactly and name the source. NIDDK states that nearly 5 out of 100 Americans ages 12 years and older have hypothyroidism, although most cases are mild or have few obvious symptoms, and that about 1 out of 100 have hyperthyroidism. Keep the qualifiers and link to the page.

Can we run a thyroid symptom quiz?

A quiz can help people decide to get checked. NIDDK says a hypothyroidism diagnosis cannot be based on symptoms alone, so the result should invite an evaluation, not state a diagnosis. Keep quiz answers away from advertising pixels.

Can we advertise a free thyroid screening?

If Medicare or Medicaid patients may respond, have counsel review the offer first. Under 42 U.S.C. 1320a-7a(a)(5), free items or services that are likely to influence a beneficiary’s choice of provider can lead to civil monetary penalties, and the OIG nominal value interpretation of $15 per item or $75 per year covers small gifts, not cash equivalents.

Can we say Medicare covers bone density tests?

You can say what Medicare.gov says: Part B covers bone mass measurements once every 24 months, or more often if medically necessary, for people who meet listed conditions, and the patient pays nothing if the provider accepts assignment. Do not imply that every Medicare patient qualifies.

Where do GLP-1 and compounded weight loss drugs fit?

Those carry FDA and FTC issues of their own, which our weight loss clinic marketing guide covers. We keep them out of this guide so the two do not drift apart.

Can we use a patient’s thyroid story on our website?

Only with a signed HIPAA authorization under 45 CFR 164.508(a)(3), and with care under 16 CFR 255.2(b): if the story is not representative, clearly disclose what patients can generally expect.

Endocrinology and thyroid practice marketing: condition pages, claims and ads